KVP Capital Advisors, LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001858198

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth Tilt how tags are computed

Q4 2025 · 25 positions · Total reported value $96.82M · Top-10 concentration 71.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 18.4% · 3 new · 1 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -13.4% · vs SPY -15.6% · Prev Value $136.24M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.0% · vs SPY -4.1% · Latest Value $122.33M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, KVP Capital Advisors, LP disclosed 25 equity positions with a combined reported value of $96.82M. The filing implies a focused portfolio: its ten largest positions account for 71.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt.

The largest disclosed positions as of Q4 2025 were TERN ($17.78M), PRAX ($12.64M), AXSM ($6.61M). By sector, the heaviest allocations are Health Care 78.5%, Other 21.5%.

Versus the prior quarter, KVP Capital Advisors, LP opened 3 new positions, trimmed 1 and fully exited 3, a turnover rate of 18.4% of positions.

The largest new positions opened in Q4 2025 were TERN ($17.78M), PRAX ($12.64M), AXSM ($6.61M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • TERN TERNS PHARMACEUTICALS INC · $17.78M
  • PRAX PRAXIS PRECISION MEDICINES I · $12.64M
  • AXSM AXSOME THERAPEUTICS INC. · $6.61M
  • WHWK WHITEHAWK THERAPEUTICS INC · $5.24M
  • TRVI TREVI THERAPEUTICS INC · $5.18M
  • INSM INSMED INC · $4.96M
  • PTGX PROTAGONIST THERAPEUTICS INC · $4.63M
  • IRON DISC MEDICINE INC · $4.63M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest KVP Capital Advisors, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

KVP Capital Advisors, LP files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 35 positions worth $136.24M in total. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).

Firm Snapshot

  • SEC registration: 801-136909 (status: Approved), registered 2026-08-20
  • Regulatory AUM (Form ADV): $123.05M as of 2026-06-29
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: kearnyvp.com

Portfolio Structure

  • 35 positions · $136.24M reported value (Q2 2026)
  • Top 10 holdings = 57.4% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 10.5%
  • Average position size: $3.89M

Sector Tilt

  • Health Care 99.8%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 2 added, 2 reduced, 3 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 78.5%
Other 21.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 440.00K $17.78M 18.36%
18.36%
New
2 42.90K $12.64M 13.06%
13.06%
New
3 36.20K $6.61M 6.83%
6.83%
New
4 2.17M $5.24M 5.41%
5.41%
New
5 414.00K $5.18M 5.35%
5.35%
New
6 28.50K $4.96M 5.12%
5.12%
New
7 53.00K $4.63M 4.78%
4.78%
New
8 58.25K $4.63M 4.78%
4.78%
New
9 121.52K $3.83M 3.96%
3.96%
New
10 605.28K $3.65M 3.77%
3.77%
New
11 91.00K $3.48M 3.59%
3.59%
New
12 133.00K $3.30M 3.41%
3.41%
New
13 17.50K $2.98M 3.07%
3.07%
New
14 59.70K $2.76M 2.85%
2.85%
New
15 4.75K $2.31M 2.39%
2.39%
New
16 462.36K $2.30M 2.37%
2.37%
New
17 27.50K $2.19M 2.26%
2.26%
New
18 45.00K $1.98M 2.05%
2.05%
New
19 32.70K $1.66M 1.71%
1.71%
New
20 230.42K $1.21M 1.25%
1.25%
New
21 26.90K $1.14M 1.18%
1.18%
New
22 505.43K $1.11M 1.14%
1.14%
New
23 50.00K $565.50K 0.58%
0.58%
New
24 4.00K $398.96K 0.41%
0.41%
New
25 500.55K $290.37K 0.30%
0.30%
New

FAQ

What did KVP Capital Advisors, LP buy in 2025-Q4?

In its 2025-Q4 13F filing, KVP Capital Advisors, LP reported 25 equity positions worth $96.82M in aggregate; its largest disclosed positions were TERN ($17.78M), PRAX ($12.64M), AXSM ($6.61M).

How large is KVP Capital Advisors, LP's portfolio?

KVP Capital Advisors, LP reported $96.82M of long equity holdings across 25 positions as of 2025-Q4. Top-10 holdings account for 71.4% of reported value.

What is KVP Capital Advisors, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/kvp-capital-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →